GHK-Cu kalkulator

What Is GHK-Cu?

GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide first isolated from human plasma in 1973 by Loren Pickart. The peptide consists of three amino acids — glycine, histidine, and lysine — chelated to a copper(II) ion. It is found in plasma, saliva, and urine and plays a central role in tissue remodeling, wound healing, and the regulation of gene expression.

Plasma concentrations of GHK-Cu are highest in youth (approximately 200 ng/mL at age 20) and decline steadily with age, dropping to around 80 ng/mL by age 60. This age-related decline correlates with slower wound healing, reduced skin elasticity, and diminished regenerative capacity across tissues. Supplementing with exogenous GHK-Cu is therefore aimed at restoring youthful signaling pathways that govern repair and antioxidant defense.

GHK-Cu has been studied extensively in dermatology, oncology, and regenerative medicine. Its mechanisms include stimulation of collagen, elastin, and glycosaminoglycan synthesis; upregulation of antioxidant enzymes; modulation of transforming growth factor beta (TGF-β); and broad anti-inflammatory activity via suppression of NF-κB signaling. In vitro and animal studies also suggest neuroprotective properties and positive effects on hair follicle proliferation.

Mechanisms of Action

The biological activity of GHK-Cu operates on several interconnected levels:

• Collagen and connective tissue synthesis: GHK-Cu stimulates fibroblasts to produce type I and type III collagen, fibronectin, and decorin, improving both wound tensile strength and skin structure. It simultaneously inhibits matrix metalloproteinases (MMPs) that degrade the extracellular matrix, creating a net anabolic effect on connective tissue.
• Antioxidant defense: The copper ion in GHK-Cu participates in superoxide dismutase (SOD) activity, reducing oxidative damage. GHK-Cu also upregulates the expression of several antioxidant genes including heme oxygenase-1 (HO-1).
• Anti-inflammatory signaling: GHK-Cu has been shown to downregulate pro-inflammatory cytokines including TNF-α and IL-6, and inhibits NF-κB — a master transcription factor for inflammatory gene expression. This makes it particularly useful for chronic inflammatory conditions and post-procedural recovery.
• Angiogenesis: GHK-Cu promotes the formation of new blood vessels by upregulating VEGF (vascular endothelial growth factor), supporting nutrient and oxygen delivery to healing tissue.
• Gene expression modulation: Research by Pickart and colleagues demonstrated that GHK-Cu modulates the expression of over 4,000 human genes — roughly 30% of the known genome — with a strong bias toward genes that suppress cancer, restore DNA repair, and reduce inflammatory damage.

Dosage and Dosing Protocol

GHK-Cu does not follow a traditional titration ramp like some research peptides. Instead, users typically begin at a therapeutic dose and maintain it throughout the protocol.

Typical Dosing Range

• Conservative dose: 1 mg/day subcutaneous
• Standard therapeutic dose: 2 mg/day subcutaneous
• Higher range: 3–4 mg/day subcutaneous (experienced users)

Protocol Structure

Most protocols run for 4–8 weeks continuously. A common approach is:

• Loading phase (weeks 1–2): 1 mg/day to assess tolerance and observe initial response, particularly skin changes, mood, and sleep quality.
• Maintenance phase (weeks 3–8): 2–3 mg/day. Inject subcutaneously into the abdomen or nearest site to the target tissue. For skin and hair goals, some users split the dose between topical application (where available) and subcutaneous injection.
• Cycle off: After 6–8 weeks, a 2–4 week break is recommended before resuming.

Injection timing is flexible. Most users administer once daily, either in the morning or at night. There is no strong evidence favoring a specific time of day for GHK-Cu.

Reconstitution

GHK-Cu is supplied as a lyophilized (freeze-dried) powder, typically in 50 mg vials. Before use it must be reconstituted with bacteriostatic water (BAC water). Standard reconstitution for a 50 mg vial:

1. Draw 5 mL of BAC water into a sterile syringe. This yields a concentration of 10 mg/mL.
2. Inject the BAC water slowly down the inner wall of the vial — do not shoot it directly onto the peptide powder, as this can denature the molecule.
3. Gently swirl the vial until fully dissolved. Do not shake or vortex.
4. Label the vial with the date of reconstitution and the concentration (10 mg/mL).

At 10 mg/mL, a standard 2 mg dose equals 0.20 mL (200 µL) drawn into an insulin syringe. Use the BergdorfBio GHK-Cu Calculator to compute exact volumes for any dose and concentration.

Storage

Proper storage is critical to preserve GHK-Cu activity:

• Lyophilized (unreconstituted) powder: Store at −20°C (freezer). Stable for 24+ months when kept dry and frozen. Refrigeration at 4°C is acceptable for short-term storage (up to 3 months) if the freezer is unavailable.
• Reconstituted solution: Refrigerate at 2–8°C. Use within 28–30 days of reconstitution. Keep away from light. Do not freeze the reconstituted solution — freezing and thawing can cause peptide aggregation and loss of potency.
• Transport: Use an ice pack or cool bag when transporting. Avoid prolonged exposure to temperatures above 25°C.

Side Effects and Safety Profile

GHK-Cu has a well-established safety profile in both topical and subcutaneous use. It is endogenous to the human body, which reduces the likelihood of immune responses.

Common Observations

• Mild redness or transient irritation at the injection site (usually resolves within hours)
• Temporary flushing or warmth — consistent with increased local blood flow and angiogenic activity
• Some users report improved sleep quality and a mild calming effect, possibly related to neuroprotective or GABAergic signaling

Rare or Reported Side Effects

• Copper overload: Theoretically possible at high doses over long cycles, but no clinical cases have been documented at standard research doses. GHK-Cu delivers copper in a biologically controlled form, distinct from raw copper supplementation.
• Hyperpigmentation: Occasionally reported in topical use, particularly around wound sites. This appears to be a transient melanin stimulation effect.
• Nausea: Rare at standard doses; more often associated with inadvertent intramuscular injection or injecting too rapidly.

No serious adverse events have been attributed to GHK-Cu in the published literature at standard research doses. However, clinical safety data in humans is limited, and all use is considered research-only.

Combinations and Stacks

GHK-Cu + BPC-157 (Glow Stack)

The combination of GHK-Cu and BPC-157 is one of the most popular repair-focused stacks — referred to at BergdorfBio as the Glow Stack. The two peptides complement each other through distinct and additive mechanisms:

• GHK-Cu drives collagen synthesis, antioxidant defense, and gene-level repair signaling.
• BPC-157 promotes angiogenesis, tendon-to-bone healing, and gut mucosal integrity, and upregulates growth hormone receptors.
• Together they create a multi-pathway regenerative environment that no single peptide achieves alone.

Typical Glow Stack protocol: GHK-Cu 2 mg/day + BPC-157 250–500 mcg/day, both subcutaneous, for 6–8 weeks. View the GHK-Cu product page to purchase from BergdorfBio.

GHK-Cu + TB-500

Adding TB-500 (Thymosin Beta-4) to GHK-Cu enhances systemic tissue repair and cell migration, making this stack a strong choice after surgery, injury, or intense training. TB-500 contributes actin-binding and anti-apoptotic effects that widen the therapeutic scope beyond what GHK-Cu alone provides.

Topical Use

GHK-Cu can also be used topically in serum form, often alongside retinoids or vitamin C. Topical GHK-Cu penetrates the dermis and has demonstrated clinically meaningful improvements in skin laxity, wrinkle depth, and overall photodamage scores in randomized trials. Subcutaneous injection delivers a higher systemic dose, but topical application is a complementary option for skin-specific goals.

Frequently Asked Questions

How quickly does GHK-Cu produce noticeable effects?

Most users notice improved skin texture and hydration within 2–3 weeks of daily subcutaneous dosing. More structural changes — collagen density, fine lines, wound healing speed — typically manifest at the 4–6 week mark. Hair benefits, if any, often require a full 8-week cycle to assess.

Can I use GHK-Cu and BPC-157 in the same syringe?

While some users do combine them in one injection, it is generally not recommended. Each peptide is reconstituted separately and their stability in a combined solution is not well characterized. Use separate syringes injected at the same site or at adjacent sites.

Does GHK-Cu affect hormones or the HPTA?

No. GHK-Cu has no known interaction with the hypothalamic-pituitary-testicular axis, thyroid function, or other endocrine systems. It does not suppress endogenous hormone production and does not require post-cycle therapy (PCT).

Is GHK-Cu suitable for women?

Yes. GHK-Cu is equally suitable for men and women. Its mechanisms are not sex-hormone dependent, and it is one of the most commonly used peptides in female anti-aging and skin health protocols.

What injection sites work best for skin and hair goals?

For systemic effects (collagen, inflammation, oxidative stress), abdominal subcutaneous injections are the most practical. For localized skin goals, some practitioners inject small amounts intradermally or subcutaneously close to the target area (e.g., scalp for hair, face perimeter for skin). This approach is more technique-sensitive and should be learned under proper guidance.

Can GHK-Cu be used during injury recovery alongside physical rehabilitation?

Yes, and this is one of its most clinically supported use cases. The combination of GHK-Cu's collagen-promoting and anti-inflammatory effects with structured physical rehabilitation has been used in athletic recovery protocols. It does not interact with NSAIDs, corticosteroids (though these may blunt its collagen effects), or physical therapy modalities.

Is there a topical alternative to injections?

Yes. GHK-Cu is available in cream and serum formulations. While topical delivery is less bioavailable than subcutaneous injection for systemic effects, it is effective for local skin applications and suitable for users who prefer to avoid injections.

What is the shelf life after reconstitution?

Reconstituted GHK-Cu stored in a refrigerator (2–8°C) is stable for approximately 28–30 days. After this period, activity may decline even if the solution appears clear. Always note the reconstitution date on the vial.

Medical Disclaimer: The information on this page is provided for educational and research purposes only. GHK-Cu is not an approved drug or medical treatment. It is sold strictly for research use. Nothing on this page constitutes medical advice, diagnosis, or a recommendation to use any specific compound. Always consult a qualified healthcare professional before beginning any peptide protocol. BergdorfBio assumes no liability for the use or misuse of the information presented here.